import
system
ra
regul
normal
physiolog
pathogenesi
cardiovascular
diseas
well
bestknown
compon
ra
includ
angiotensinogen
angiotensin
ii
peptidas
renin
angiotensinconvert
enzym
ace
renin
ratelimit
enzym
ra
wherea
angiotensin
ii
major
effector
molecul
exert
biolog
action
via
angiotensin
ii
angiotensin
ii
receptor
angiotensin
ii
gener
circul
within
tissu
local
ra
ra
implic
pathogenesi
variou
cardiovascular
disord
includ
hypertens
atherosclerosi
myocardi
infarct
patholog
cardiac
remodel
heart
failur
metabol
product
angiotensin
identifi
recent
aforement
compon
system
thought
counteract
effect
advers
action
ra
compon
figur
although
physiolog
pathophysiolog
role
incomplet
understood
find
numer
experiment
studi
suggest
notabl
protect
effect
heart
blood
vessel
kidney
central
nervou
system
angiotensin
might
therefor
repres
new
therapeut
target
cardiovascular
review
summar
evid
experiment
clinic
studi
effect
angiotensin
variou
patholog
cardiovascular
condit
also
known
acerel
carboxypeptidas
angiotensinconvert
enzym
homologu
aceh
monocarboxypeptidas
mainli
express
vascular
endotheli
cell
renal
tubular
gene
clone
two
independ
group
homologu
human
protein
aminoacid
typei
transmembran
protein
contain
extracellular
ecto
domain
amino
acid
transmembran
region
amino
acid
intracellular
tail
extracellular
part
figur
contain
catalyt
domain
amino
acid
substrat
bind
region
amino
acid
typic
hemgh
metalloproteinas
zincbind
site
amino
acid
ctermin
part
homolog
ident
transport
protein
known
catalyt
domain
ident
peptidas
activ
depend
cterminu
sequenc
substrat
sequenc
specif
substrat
gener
hydrophob
basic
residu
ctermin
end
preced
proxpro
motif
either
one
two
prolin
residu
suffici
allow
circumst
display
potent
peptidas
activ
angiotensin
ii
proph
angiotensin
prophehisleu
bradykinin
serproph
show
activ
toward
angiotensin
angiotensin
also
hydrolys
bioactiv
peptid
dynorphin
mostimport
activ
product
angiotensin
primarili
gener
via
two
rout
first
directli
hydrolys
angiotensin
ii
yield
angiotensin
second
convert
angiotensin
angiotensin
cleav
either
neutral
endopeptidas
nep
ace
yield
angiotensin
addit
angiotensin
produc
prolyl
carboxypeptidas
angiotensin
ii
nep
directli
angiotensin
biolog
function
angiotensin
poorli
understood
although
import
effect
cardiovascular
system
affin
angiotensin
ii
km
repres
concentr
substrat
requir
enzym
achiev
half
maximum
catalyt
veloc
higher
km
valu
lower
affin
higher
angiotensin
km
catalyt
effici
angiotensin
ii
time
angiotensin
angiotensin
pathway
figur
ought
therefor
predomin
role
product
angiotensin
vivo
membranebound
ectodomain
cleav
metalloproteinas
releas
solubl
form
figur
use
serial
delet
construct
iwata
colleagu
identifi
juxtamembran
region
amino
acid
essenti
ectodomain
physiolog
relev
solubl
fulli
understood
activ
plasma
rais
patient
chronic
heart
associ
increas
cardiac
dysfunct
poor
clinic
moreov
solubl
activ
rais
myocardi
infarct
associ
increas
incid
subsequ
advers
left
ventricular
find
one
studi
suggest
angiotensin
ii
promot
shed
increas
activ
myocardium
action
repres
posit
feedback
mechan
angiotensin
ii
facilit
myocardi
sever
compound
known
affect
activ
specif
potent
inhibitor
half
maximum
inhibitori
concentr
xray
diffract
studi
reveal
catalyt
domain
contain
two
subdomain
link
hing
region
form
long
deep
cleft
bind
subdomain
figur
caus
hing
flex
shrink
cleft
prevent
substrat
inhibit
vivo
aggrav
glomerular
injuri
model
type
diabet
exacerb
cardiac
hypertrophi
fibrosi
transgen
hypertens
peptid
inhibitor
high
affin
kd
nmoll
valu
equilibr
concentr
requir
achiev
occup
receptor
radioligand
bind
assay
higher
kd
valu
lower
affin
high
efficaci
nmoll
obviou
inhibitori
effect
toward
vitro
vivo
experi
shown
antagonist
effect
kinet
analys
reveal
exhibit
mix
competit
noncompetit
type
inhibit
indic
peptid
might
act
partial
alloster
modul
mode
action
analog
ace
inhibitor
sever
studi
report
display
differ
efficaci
inhibit
human
rodent
given
potenti
protect
role
cardiovascular
system
identif
novel
activ
import
avenu
drug
discoveri
two
smallmolecul
enhanc
xanthenon
resorcinolnaphthalein
vitro
compound
enhanc
activ
around
twofold
concentr
show
effect
ace
activ
pharmacolog
effect
xanthenon
explor
vivo
healthi
normal
rat
spontan
hypertens
rat
shr
show
remark
hypotens
cardiac
protect
potent
antithrombot
action
report
xanthenon
rat
model
venou
thrombosi
wherea
led
opposit
benefici
effect
howev
interpret
caution
xanthenon
increas
inde
specif
xanthenon
addit
rout
angiotensin
gener
directli
angiotensin
prolyl
endopeptidas
heart
brain
kidney
major
sourc
angiotensin
human
coronari
circul
nep
seem
morepromin
role
angiotensin
product
pharmacokinet
experi
determin
human
angiotensin
short
halflif
follow
subcutan
inject
peptid
quickli
avail
blood
reach
peak
plasma
concentr
rat
plasma
halflif
angiotensin
angiotensin
metabol
mainli
ace
addit
aminopeptidas
nep
degrad
angiotensin
peptid
angiotensin
broad
effect
cardiovascular
system
includ
vasodilat
myocardi
protect
antiarrhythm
antihypertens
posit
inotrop
effect
inhibit
patholog
cardiac
addit
angiotensin
thought
favour
effect
metabol
lessen
insulin
although
effect
protect
seem
variabl
exampl
effect
arrhythmia
might
biphas
high
concentr
angiotensin
promot
cardiac
arrhythmia
low
concentr
protect
similarli
experiment
find
suggest
biolog
function
angiotensin
kidney
might
benefici
diuret
natriuret
antifibrot
antiprolif
wherea
find
suggest
detriment
antidiuret
proinflammatori
profibrot
although
biolog
action
angiotensin
well
describ
signal
mechan
still
poorli
understood
treatment
angiotensin
activ
pathway
action
could
least
partli
explain
benefici
effect
angiotensin
blood
vessel
function
metabol
given
pivot
role
akt
promot
endotheli
nitric
oxid
synthas
function
insulin
contrast
angiotensin
inhibitori
effect
activ
mitogenactiv
protein
kinas
mapk
pathway
endotheli
smoothmuscl
cardiac
renal
proxim
tubular
cell
angiotensin
ii
induc
oxid
hypertroph
prolif
respons
activ
mapk
therefor
angiotensin
might
counterregul
effect
effect
angiotensin
mapk
howev
highli
cell
specif
type
cell
angiotensin
augment
basal
angiotensiniiinduc
mapk
smoothmuscl
depolar
via
angiotensin
open
potassium
channel
demonstr
seem
depend
activ
protein
kinas
pka
earli
radioligandbind
studi
indic
angiotensin
could
bind
receptor
brain
although
studi
use
morehomogen
assay
system
virtual
bind
observ
cell
stabli
express
angiotensin
bind
receptor
moder
affin
five
time
lower
angiotensin
ii
studi
demonstr
certain
biolog
effect
angiotensin
attenu
use
receptor
antagonist
therefor
angiotensin
bind
receptor
function
relev
ma
protein
origin
clone
oncogen
seventransmembran
gproteincoupl
receptor
high
affin
angiotensin
kd
nmoll
gene
protein
mainli
express
brain
testi
kidney
express
level
ma
dynam
regul
physiolog
patholog
stimuli
ma
express
also
observ
vascular
endotheli
express
ma
remain
confirm
vascular
smoothmuscl
cell
although
angiotensin
effect
readili
observ
cell
variou
function
anim
show
cardiovascularrel
phenotyp
includ
myocardi
contractil
dysfunct
cardiac
fibrosi
hypertens
endotheli
dysfunct
renal
fibrosi
glomerular
dysfunct
insulin
resist
howev
two
studi
differ
model
hypertens
twokidney
oneclip
model
hypertens
induc
respons
high
salt
ingest
assess
ma
defici
opposit
effect
blood
function
studi
suggest
cardiovascular
effect
angiotensin
like
mediat
precis
angiotensin
signal
mechan
context
cardiovascular
physiolog
howev
firmli
establish
first
oncogen
activ
ma
signal
induc
cell
transform
via
small
gtpase
effect
reproduc
angiotensin
rather
antitumorigen
second
ma
constitut
coupl
downstream
phospholipas
kinas
c
evid
indic
howev
angiotensin
stimul
signal
masexpress
moreov
ectop
express
ma
induc
increas
intracellular
concentr
wherea
angiotensin
treatment
rais
intracellular
concentr
third
mechanist
link
ma
akt
pathway
implic
cardioprotect
action
angiotensin
still
miss
mani
circumst
effect
angiotensin
antagonist
induc
angiotensin
ii
cardiovascular
underli
signal
mechan
remain
defin
ma
bind
directli
receptor
interact
unlik
role
mediat
angiotensin
effect
sinc
administr
angiotensin
effect
despit
discoveri
bind
ma
still
classifi
class
orphan
receptor
latest
intern
union
basic
clinic
pharmacolog
wide
use
ma
antagonist
angiotensin
angiotensin
analogu
last
prolin
residu
substitut
agent
water
solubl
radioligandbind
experi
show
angiotensin
high
efficaci
ma
inhibit
angiotensin
bind
nmoll
contrast
bind
affin
angiotensin
receptor
similar
peptid
ma
antagonist
angiotensin
pharmacolog
properti
agent
fulli
character
exhibit
similar
effect
angiotensin
compet
angiotensin
bind
show
weak
affin
current
specif
nonpeptid
ma
antagonist
avail
ave
smallmolecul
agonist
high
affin
select
ma
compet
specif
bind
angiotensin
moll
virtual
affin
maximum
stimul
effect
ave
releas
endotheli
nitric
oxid
equival
angiotensin
amino
acid
peptid
obviou
homolog
angiotensin
fragment
known
endogen
gpcr
equal
potent
angiotensin
ma
receptor
bind
agent
bind
activ
receptor
show
moder
bind
affin
receptor
seem
benefici
effect
regul
blood
pressur
tabl
figur
mice
rais
basal
blood
pressur
notabl
amplif
angiotensiniiinduc
hypertens
increas
accumul
angiotensin
ii
plasma
kidney
angiotensin
ii
gainoffunct
experi
shr
indic
express
central
nervou
system
associ
substanti
decreas
blood
pressur
exampl
overexpress
human
rostral
ventrolater
medulla
produc
longterm
hypotens
effect
similarli
overexpress
paraventricular
nucleu
amelior
hypertens
induc
angiotensin
ii
healthi
normal
moreov
panneuron
express
brain
deliveri
adenovirus
cerebr
ventricl
attenu
high
blood
pressur
improv
baroreflex
dysfunct
induc
angiotensin
addit
central
action
target
express
human
vascular
smooth
muscl
cell
decreas
blood
pressur
strokepron
pharmacolog
intervent
studi
reveal
similar
benefici
effect
high
blood
pressur
system
administr
human
recombin
counteract
pressor
effect
induc
angiotensin
ii
associ
acceler
clearanc
circul
angiotensin
moreov
shr
chronic
treatment
result
sustain
decreas
blood
murin
recombin
similar
antihypertens
effect
human
hypertens
induc
angiotensin
likewis
chronic
infus
compound
xanthenon
slightli
decreas
blood
pressur
contrast
report
protect
effect
experiment
hypertens
studi
angiotensin
yield
rather
heterogen
result
tabl
studi
shown
acut
system
infus
angiotensin
either
rat
normal
blood
pressur
hypertens
due
variou
aetiolog
chang
blood
decreas
mean
blood
pressur
dahl
saltsensit
rat
howev
anaesthet
mice
bolu
administr
angiotensin
show
effect
angiotensiniiinduc
elev
blood
pressur
bloodpressur
recoveri
inject
angiotensin
ii
healthi
normal
rat
acut
infus
angiotensin
led
enhanc
hypotens
effect
chronic
treatment
angiotensin
associ
transient
sustain
reduct
blood
pressur
variou
hypertens
model
includ
shr
dahl
saltsensit
deoxycorticosteroneacet
doca
salttreat
result
twokidney
oneclip
model
hypertens
rat
moreov
chronic
angiotensin
treatment
observ
increas
blood
pressur
rat
hypertens
induc
subtot
administr
angiotensin
central
nervou
system
rat
induc
null
hypertens
hypotens
effect
intracerebroventricular
infus
angiotensin
show
effect
rat
normal
blood
lower
blood
pressur
doca
aldosteron
salthypertens
convers
inject
angiotensin
rostral
ventrolater
medulla
trigger
increas
blood
pressur
rat
normal
blood
pressur
anaesthet
mice
acut
treatment
angiotensin
show
effect
basal
angiotensiniiinduc
systol
acut
central
administr
angiotensin
chang
mean
arteri
blood
chronic
treatment
modifi
blood
rat
normal
blood
pressur
shr
angiotensin
given
central
system
howev
antagon
hypotens
action
transgen
worsen
hypertens
baroreflex
dysfunct
variou
acut
infus
monoclon
antibodi
angiotensin
shr
notabl
rais
blood
human
infus
angiotensin
induc
notabl
vasodil
effect
control
individu
normal
blood
pressur
patient
yet
anoth
studi
acut
infus
angiotensin
chang
blood
pressur
individu
normal
blood
taken
togeth
result
suggest
potenti
bloodpressurelow
effect
via
multipl
mechan
among
catabol
angiotensin
ii
like
essenti
figur
contrast
function
import
angiotensin
product
remain
confirm
express
atherosclerot
lesion
anim
human
role
atherogenesi
figur
investig
use
variou
vivo
system
overexpress
suppress
atherogenesi
apolipoproteineknockout
similar
antiatherosclerot
effect
seen
rabbit
fed
highcholesterol
overexpress
also
stabil
atherosclerot
plaqu
via
inhibit
inflamm
product
matrix
metalloproteinas
effect
revers
angiotensin
convers
lossoffunct
mutat
promot
plaqu
accumul
increas
express
inflammatori
adhes
molecul
similar
angiotensin
benefici
effect
experiment
atherosclerosi
figur
longterm
treatment
angiotensin
apolipoproteineknockout
mice
prevent
progress
atherosclerot
lesion
improv
endotheli
function
nitric
effect
seem
involv
ma
receptor
system
administr
angiotensin
inhibit
atherosclerot
lesion
format
enhanc
plaqu
stabil
mice
dosedepend
manner
effect
associ
decreas
prolifer
migrat
vascular
smooth
muscl
cell
decreas
macrophag
releas
inflammatori
activ
angiotensin
receptor
ave
also
inhibit
atherogenesi
apolipoproteineknockout
atheroprotect
action
angiotensin
could
relat
inhibitori
effect
vascular
inflamm
smoothmusclecel
prolifer
migrat
probabl
via
masmedi
suppress
nuclear
factor
mapk
pathway
although
angiotensin
alon
modul
earli
atherogenesi
seem
aggrav
destabil
atherosclerot
origin
clone
heartfailureassoci
gene
heart
tissu
patient
idiopath
dilat
studi
unequivoc
confirm
cardiac
express
chang
human
heart
level
activ
solubl
plasma
seem
increas
patient
heart
associ
polymorph
hypertroph
cardiomyopathi
also
show
multipl
benefici
effect
left
ventricular
remodel
dysfunct
rat
model
cardiac
hypertrophi
induc
angiotensin
ii
diabet
cardiomyopathi
induc
streptozotocin
myocardi
infarct
induc
coronari
arteri
mice
right
ventricular
dysfunct
induc
pressur
overload
treatment
recombin
human
reduc
ventricular
hypertrophi
improv
systol
diastol
contrast
knockout
augment
angiotensiniiinduc
myocardi
hypertrophi
interstiti
fibrosi
acceler
transit
hypertrophi
heart
knockout
also
aggrav
cardiac
dysfunct
induc
diabet
although
cardioprotect
mechan
complet
clear
mediat
angiotensin
ii
catabol
subsequ
inhibit
angiotensiniiinduc
oxid
stress
inflamm
interstiti
fibrosi
thought
import
role
figur
addit
reduct
sympathet
nerv
activ
might
attribut
cardioprotect
demonstr
studi
central
overexpress
figur
product
angiotensin
substanti
increas
heart
failur
induc
myocardi
date
studi
support
angiotensin
protect
effect
patholog
cardiac
remodel
heart
failur
figur
instanc
system
infus
angiotensin
prevent
develop
heart
failur
follow
myocardi
infarct
angiotensin
receptor
agonist
ave
show
similar
benefici
infus
angiotensin
also
prevent
cardiac
remodel
induc
angiotensin
ii
diabetesinduc
diastol
dysfunct
preserv
eject
fraction
dbdb
testisspecif
angiotensin
transgen
rat
doubl
concentr
circul
angiotensin
notabl
protect
effect
myocardi
hypertrophi
fibrosi
induc
treatment
angiotensin
also
produc
equival
protect
action
pressureoverloadinduc
cardiac
hypertrophi
remodel
blockad
cardiac
protect
action
angiotensin
unlik
primarili
mediat
local
mechan
myocardium
sinc
effect
cardiomyocyterestrict
overexpress
patholog
cardiac
remodel
seem
addit
effect
angiotensin
arrhythmia
biphas
benefici
effect
myocardium
associ
low
concentr
aris
induct
hyperpolar
increas
conduct
veloc
refractori
wherea
high
concentr
arrhythmogen
whether
angiotensin
lead
cardiac
dysfunct
remodel
rodent
model
renal
diseas
involv
angiotensin
modul
cerebr
vascular
function
process
ischaem
stroke
figur
support
sever
studi
ex
vivo
prepar
canin
middl
cerebr
arteri
feterik
et
demonstr
angiotensin
induc
endotheliumdepend
relax
sensit
blockad
nitric
oxid
synthas
solubl
guanylyl
cyclas
relax
induc
angiotensin
affect
angiotensin
receptor
antagonist
partial
block
bradykinin
receptor
similar
vasodilatori
effect
observ
rat
middl
cerebr
moreov
chronic
intraven
infus
angiotensin
revers
endotheli
dysfunct
middl
cerebr
arteri
rat
maintain
highsalt
rat
acut
ischaem
stroke
express
ma
upregul
concentr
local
circul
angiotensin
substanti
rat
model
stroke
induc
occlus
middl
cerebr
arteri
pretreat
angiotensin
intracerebroventricular
infus
associ
reduct
infarct
size
sever
neurolog
deficit
effect
block
administr
angiotensin
neural
protect
action
angiotensin
brain
ischaemia
howev
unlik
relat
alter
cerebr
blood
flow
rather
seem
mediat
antiinflammatori
effect
angiotensin
evidenc
reduct
express
induc
nitric
oxid
synthas
activ
nuclear
factor
oxid
stress
releas
proinflammatori
cytokin
injur
brain
accumul
evid
suggest
function
angiotensin
affect
diabet
addit
howev
angiotensin
substanti
affect
glucos
metabol
suggest
could
potenti
benefici
effect
patient
diabet
figur
circul
activ
increas
streptozotocintr
rat
diabet
nonobes
mice
likewis
activ
serum
increas
human
type
ectop
express
human
pancrea
young
dbdb
mice
associ
significantli
decreas
hyperglycaemia
improv
islet
function
reduc
effect
prevent
administr
angiotensin
convers
defici
aggrav
impair
glucos
toler
insulin
sensit
induc
increas
circul
concentr
angiotensin
result
chronic
infus
transgen
express
amelior
hyperinsulinaemia
insulin
resist
inflammatori
respons
adipos
tissu
overnourish
increas
insulin
sensit
glucos
toler
normoglycaem
moreov
rat
model
type
diabet
chronic
oral
treatment
angiotensin
formula
induc
substanti
hypoglycaem
effect
improv
insulin
sensit
prevent
mechan
underli
benefici
action
angiotensin
glucos
metabol
could
multifacet
first
activ
ra
especi
local
ra
instanc
skelet
muscl
adipos
tissu
pancrea
contribut
notabl
develop
insulin
resist
henc
increas
degrad
angiotensin
ii
might
import
glucos
metabol
second
angiotensin
activ
therebi
facilit
insulininduc
signal
glucos
uptak
angiotensin
might
also
antagon
dysfunct
insulin
signal
induc
angiotensin
ii
prevent
serin
phosphoryl
insulin
receptor
substrat
probabl
via
inhibit
activ
mapk
pathway
induc
angiotensin
moreov
evid
suggest
angiotensin
facilit
glucos
uptak
upregul
glucos
transport
type
express
major
glucos
transport
angiotensin
shown
remark
protect
action
diabet
nephropathi
sever
studi
clinic
experiment
studi
reveal
reduc
express
kidney
set
diabet
associ
kidney
inhibit
worsen
glomerular
injuri
mice
streptozotocininduc
knockout
acceler
diabetesinduc
kidney
increas
function
akita
mice
diabet
system
treatment
recombin
howev
amelior
albuminuria
prevent
glomerular
prolifer
fibrosi
oxid
rat
diabet
global
overexpress
produc
remark
renal
protect
similar
induc
ace
inhibitor
benazepril
synergist
action
ace
inhibit
local
overexpress
renal
podocyt
also
seem
prevent
kidney
injuri
mice
addit
chronic
system
treatment
angiotensin
reduc
risk
renal
fibrosi
oxid
stress
inflamm
zucker
obes
rat
model
type
highli
express
gut
tissu
least
gut
shown
critic
role
regul
intestin
innat
immun
amino
acid
homeostasi
ecolog
gut
defici
result
increas
suscept
intestin
inflamm
induc
epitheli
note
evid
suggest
metabol
dietari
compon
intestin
microbiota
might
also
effect
cardiovascular
rais
possibl
express
gut
contribut
vascular
protect
indirectli
modul
interact
gut
microbiota
intestin
epithelium
success
chemic
ace
inhibitor
blocker
clinic
manag
variou
cardiovascular
diseas
underscor
possibl
search
chemic
modul
target
activ
compon
ra
could
fruit
firstinhuman
studi
human
recombin
administ
intraven
healthi
volunt
assess
pharmacokinet
pharmacodynam
safeti
profil
nativ
bioavail
recombin
human
bodi
show
linear
dosedepend
increas
termin
elimin
halflif
h
strikingli
within
min
administr
plasma
concentr
angiotensin
ii
drop
remain
suppress
h
level
angiotensin
vari
respons
differ
dose
recombin
well
toler
obviou
effect
haemodynam
result
also
highlight
possibl
human
potenti
cardiovascular
protect
action
rais
concentr
might
larg
mediat
acceler
catabol
angiotensin
ii
basic
pharmacokinet
safeti
profil
nativ
angiotensin
mainli
obtain
sever
studi
patient
nativ
angiotensin
caus
vasodilat
healthi
individu
patient
show
effect
patient
heart
angiotensin
continu
catabol
ace
nep
aminopeptidas
therefor
decreas
degrad
seem
plausibl
contributor
benefici
effect
ace
valu
angiotensin
therapeut
agent
could
limit
short
halflif
peptid
bodi
aceresist
cyclic
angiotensin
analogu
thioether
bridg
introduc
modifi
residu
angiotensin
bridg
peptid
highli
resist
ace
activ
show
substanti
reduct
plasma
clearanc
rat
moreov
agent
induc
masdepend
vasodil
effect
isol
rat
thioetherbridg
angiotensin
stabl
low
ph
bioavail
oral
administr
rat
model
myocardi
infarct
chronic
infus
thioetherbridg
angiotensin
start
week
infarct
suppress
myocyt
hypertrophi
improv
cardiac
vascular
hydroxypropyl
angiotensin
formul
design
overcom
instabl
nativ
angiotensin
gastrointestin
tract
oral
treatment
shown
remark
cardioprotect
effect
rat
myocardi
infarct
patholog
remodel
coronari
arteri
moreov
oral
administ
associ
improv
lipid
metabol
prevent
hepat
steatosi
mice
fed
highfat
similarli
longterm
oral
treatment
found
revers
establish
hyperglycaemia
improv
insulin
sensit
prevent
diabet
nephropathi
transgen
rat
model
insulin
resist
type
understand
role
angiotensin
mainli
deriv
studi
experiment
evid
biolog
action
human
spars
nevertheless
new
drug
pharmaceut
formul
target
angiotensin
expect
strong
clinic
potenti
treat
cardiovascular
diseas
especi
associ
increas
activ
convent
ra
research
take
variou
includ
modif
nativ
angiotensin
identif
compound
specif
modul
function
underway
latter
might
includ
smallmolecul
activ
angiotensin
mimet
clearli
random
control
clinic
trial
requir
assess
therapeut
efficaci
safeti
target
intervent
numer
experiment
studi
suggest
protect
effect
heart
blood
vessel
primarili
modul
homeostasi
system
neurohumor
factor
improv
cardiovascular
risk
factor
catabol
angiotensin
ii
like
major
role
cardiovascular
protect
especi
patient
overact
ra
intervent
target
therefor
might
repres
promis
direct
discoveri
novel
therapi
cardiovascular
diseas
contrast
physiolog
pharmacolog
action
angiotensin
complex
even
paradox
certain
circumst
kidney
similarli
effect
angiotensin
bloodpressur
regul
variabl
infus
angiotensin
induc
either
vasodilat
null
effect
normotens
human
effect
angiotensin
cardiac
dysfunct
remodel
caus
renal
diseas
rodent
contradictori
differ
studi
moreov
angiotensin
show
biphas
action
cardiac
arrhythmia
follow
myocardi
injuri
therefor
studi
especi
control
clinic
trial
need
clearli
delin
benefit
therapi
articl
review
paper
select
pubm
databas
use
search
term
angiotensinconvert
enzym
angiotensin
ma
plu
identifi
includ
limit
hypertens
blood
pressur
atherosclerosi
heart
cardiac
remodel
diabet
insulin
resist
hyperinsulinaemia
stroke
cerebr
vascular
review
articl
filter
use
search
term
review
pt
articl
relat
biochemistri
pharmacolog
search
use
term
includ
biochemistri
inhibitor
antagonist
agonist
activ
bind
affin
ligand
bind
pharmacokinet
pharmacodynam
occas
term
includ
domain
structur
domain
crystallographi
also
use
gener
search
internet
appli
restrict
date
public
origin
work
articl
publish
english
includ
paper
cite
fulltext
articl
select
refer
list
retriev
paper
use
identifi
relev
citat
revis
stage
search
updat
refer
list
latest
publish
articl
